tucatinib with t-dm1 for her2-positive metastatic breast cancer
Published 2 years ago • 22 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer
-
3:58
frontline t-dm1 in her2-positive metastatic breast cancer
-
4:48
alpelisib and t-dm1 for her2-positive metastatic breast cancer
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
2:35
tucatinib with capecitabine and trastuzumab in advanced her2-positive breast cancer
-
9:38
role of t-dm1 in her2-positive metastatic breast cancer
-
7:38
tucatinib plus trastuzumab & capecitabine for patients with her2-positive breast cancer & brain mets
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
4:58
tucatinib and hrqol among patients with her2 metastatic breast cancer
-
5:50
her2climb: investigating tucatinib with capecitabine and trastuzumab in her2-positive metastatic...
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
4:30
tucatinib for the treatment of her2 breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
5:08
new quality-of-life data for tucatinib in her2 breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
3:29
t-dm1 vs. trastuzumab as adjuvant therapy for her2-positive breast cancer